DealIntel vs Crexi
The short answer
Crexi is a commercial real-estate marketplace and auction platform. DealIntel is a residential fix-and-flip underwriting platform. If those two sentences sound like different categories of tool — that is correct. They are.
For operators who genuinely do both residential and commercial work, the answer is to use Crexi for the commercial side and DealIntel for the residential side. For operators focused on residential, Crexi is largely the wrong tool.
What Crexi does well
Tech-forward UX
Crexi is generally regarded as the better-designed CRE marketplace in the US — cleaner search, faster page loads, better mobile.
Auction marketplace
Crexi runs a substantial CRE auction layer — buyers bid on properties live with structured timelines. Useful for operators who want exposure to auction inventory in CRE.
Crexi Intelligence (analytics)
On-platform analytics surface comparable sales, tenant info, market-level metrics. Closer to underwriting-adjacent than LoopNet's pure listings model.
Side by side
When to use Crexi
- You are evaluating commercial real estate — office, retail, industrial, hospitality.
- You want exposure to CRE auction inventory.
- You want CRE-specific analytics (cap rate, NOI, comp sales, tenant data).
- You are a CRE broker, owner, or institutional investor transacting in commercial.
When to use DealIntel
- You are evaluating residential fix & flip — single-family or 2–4 unit multifamily.
- You need ARV, MAO, 25-point Kill List, six-strategy comparison on residential properties.
- You compare hard money, DSCR, construction, and conventional financing on residential deals.
- You produce institutional memoranda for residential capital partners.
Related comparisons
- DealIntel vs LoopNet — the other major US commercial marketplace.
- DealIntel vs Zillow — residential consumer listings + Zestimate.
- DealIntel vs Redfin — residential listings + brokerage.
- DealIntel vs Realtor.com — NAR MLS-direct residential listings.
- DealIntel vs BiggerPockets — community + per-strategy calculators.
- DealIntel vs PropStream — residential lead-generation.
Frequently asked questions
Is DealIntel a replacement for Crexi?
No. Crexi is a US commercial real-estate marketplace — listings, auctions, and analytics for office, retail, industrial, hospitality, and multifamily 5+ units. DealIntel is a residential fix-and-flip underwriting platform. They serve different asset classes.
Can I find residential fix-and-flip deals on Crexi?
Effectively no. Crexi inventory is commercial-grade — even multifamily on the platform is typically 5+ units (commercial financing tier). Single-family flip inventory is essentially absent. For residential fix-and-flip, use Zillow, Redfin, Realtor.com, MLS, or wholesalers for sourcing and DealIntel for underwriting.
How is Crexi different from LoopNet?
Both are US commercial real-estate marketplaces. Crexi is newer and generally regarded as more tech-forward — cleaner UX, broader auction inventory, stronger on-platform analytics (Crexi Intelligence). LoopNet is owned by CoStar and remains the largest by listing volume. Neither is built for residential fix-and-flip.
Does Crexi have institutional underwriting tools?
Crexi Intelligence (the platform's analytics layer) surfaces comparable sales, price-per-sqft data, tenant info, and market-level analytics — useful for CRE underwriting. It is not built for residential fix-and-flip ARV, kill-list screening, or six-strategy parallel comparison. Those are DealIntel-specific.
Should I use Crexi and DealIntel together?
Only if you operate in both residential and commercial. For pure residential fix-and-flip, Crexi is the wrong tool — the inventory mismatch is structural. For commercial value-add, DealIntel is the wrong tool — DealIntel does not cover commercial asset classes.
Matt Abadi is the founder of DealIntel. He leads the development of the platform's six-strategy underwriting engine, 25-point Kill List, and Monte-Carlo financial model — the institutional analysis stack DealIntel applies to every fix and flip deal. DealIntel was founded in 2025 with the central thesis that knowing when not to invest is the most valuable number on the page.